The relative eosinophil count in breast cancer as an emerging prognostic biomarker

被引：0
|
作者：
Onesti, C. E. [1 ]
Josse, C. [2 ]
Beaumecker, B. [1 ]
Boulet, D. [2 ]
Thiry, J. [2 ]
Bours, V. [2 ]
Jerusalem, G. [1 ]
机构：
[1] CHU Liege, Med Oncol, Liege, Belgium
[2] GIGA Res Ctr, Lab Human Genet, Liege, Belgium
来源：
EUROPEAN JOURNAL OF CANCER | 2020年 / 138卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
343
引用
收藏
页码：S86 / S87
页数：2
相关论文
共 50 条
  • [21] Low Pre-Treatment Count of Circulating Endothelial Progenitors as a Prognostic Biomarker of the High Risk of Breast Cancer Recurrence
    Rhone, Piotr
    Bielawski, Kornel
    Ziolkowska, Katarzyna
    Rosc, Danuta
    Ruszkowska-Ciastek, Barbara
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (11)
  • [22] NDRG1 is a prognostic biomarker in breast cancer and breast cancer brain metastasis
    Joshi, Vaibhavi
    Stacey, Andrew
    Feng, Yufan
    Kalita-de Croft, Priyakshi
    Duijf, Pascal H. G.
    Simpson, Peter T.
    Lakhani, Sunil R.
    Reed, Amy E. McCart
    JOURNAL OF PATHOLOGY CLINICAL RESEARCH, 2024, 10 (02):
  • [23] Combination of lymphocyte count and albumin concentration as a new prognostic biomarker for rectal cancer
    Yamamoto, Takehito
    Kawada, Kenji
    Hida, Koya
    Matsusue, Ryo
    Itatani, Yoshiro
    Mizuno, Rei
    Yamaguchi, Takashi
    Ikai, Iwao
    Sakai, Yoshiharu
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [24] Combination of lymphocyte count and albumin concentration as a new prognostic biomarker for rectal cancer
    Takehito Yamamoto
    Kenji Kawada
    Koya Hida
    Ryo Matsusue
    Yoshiro Itatani
    Rei Mizuno
    Takashi Yamaguchi
    Iwao Ikai
    Yoshiharu Sakai
    Scientific Reports, 11
  • [25] Changes in Biomarker Status in Metastatic Breast Cancer and Their Prognostic Value
    Woo, Ji Won
    Chung, Yul Ri
    Ahn, Soomin
    Kang, Eunyoung
    Kim, Eun-Kyu
    Kim, Se Hyun
    Kim, Jee Hyun
    Kim, In Ah
    Park, So Yeon
    JOURNAL OF BREAST CANCER, 2019, 22 (03) : 439 - 452
  • [26] Endocan as a prognostic biomarker of triple-negative breast cancer
    Sagara, Atsunobu
    Igarashi, Katsuhide
    Otsuka, Maky
    Kodama, Akihiro
    Yamashita, Mutsumi
    Sugiura, Rei
    Karasawa, Takeshi
    Arakawa, Kazuhiko
    Narita, Michiko
    Kuzumaki, Naoko
    Narita, Minoru
    Kato, Yoshinori
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 161 (02) : 269 - 278
  • [27] Novel Prognostic Biomarker Using MicroRNA Signature of Breast Cancer
    Kawaguchi, T.
    Yan, L.
    Qi, Q.
    Liu, S.
    Takabe, K.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : S57 - S57
  • [28] The role of Survivin as a biomarker and potential prognostic factor for breast cancer
    da Veiga, Glaucia Luciano
    Machado da Silva, Raissa Daniel
    Pereira, Edimar Cristiano
    Azzalis, Ligia Ajaime
    Aguiar Alves, Beatriz da Costa
    Gehrke, Flovia de Sousa
    Gascon, Thais Moura
    Affonso Fonseca, Fernando Luiz
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2019, 65 (06): : 893 - 901
  • [29] Identification of CISD1 as a Prognostic Biomarker for Breast Cancer
    Liu, Xiao
    Cui, Qianqian
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2022, 15 : 8451 - 8465
  • [30] Endocan as a prognostic biomarker of triple-negative breast cancer
    Atsunobu Sagara
    Katsuhide Igarashi
    Maky Otsuka
    Akihiro Kodama
    Mutsumi Yamashita
    Rei Sugiura
    Takeshi Karasawa
    Kazuhiko Arakawa
    Michiko Narita
    Naoko Kuzumaki
    Minoru Narita
    Yoshinori Kato
    Breast Cancer Research and Treatment, 2017, 161 : 269 - 278
12345